Class information for: |
Basic class information |
Class id | #P | Avg. number of references |
Database coverage of references |
---|---|---|---|
18537 | 547 | 34.3 | 71% |
Hierarchy of classes |
The table includes all classes above and classes immediately below the current class. |
Cluster id | Level | Cluster label | #P |
---|---|---|---|
0 | 4 | BIOCHEMISTRY & MOLECULAR BIOLOGY//CELL BIOLOGY//ONCOLOGY | 4064930 |
285 | 3 | ERDOSTEINE//PEROXIREDOXIN//GLUTATHIONE | 42405 |
3501 | 2 | AMBROXOL//ERDOSTEINE//N ACETYLCYSTEINE | 1436 |
18537 | 1 | N ACETYLCYSTEINE//CARDIOVASC SURG CIRCULAT PHYSIOPATHOL//CYTIOLONE | 547 |
Terms with highest relevance score |
rank | Term | termType | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|---|
1 | N ACETYLCYSTEINE | authKW | 686086 | 27% | 8% | 145 |
2 | CARDIOVASC SURG CIRCULAT PHYSIOPATHOL | address | 111644 | 0% | 100% | 2 |
3 | CYTIOLONE | authKW | 111644 | 0% | 100% | 2 |
4 | NAC TREATMENT | authKW | 111644 | 0% | 100% | 2 |
5 | ACETYLCYSTEINE | authKW | 104304 | 4% | 9% | 20 |
6 | MUCOLYTICS | authKW | 78521 | 2% | 13% | 11 |
7 | INNOVAT MED SCI | address | 74428 | 0% | 67% | 2 |
8 | CAS 616 91 1 | authKW | 71768 | 1% | 43% | 3 |
9 | N ACETYL L CYSTEINE | authKW | 71316 | 4% | 6% | 21 |
10 | EXPECTORANTS THERAPEUTIC USE | authKW | 62796 | 1% | 38% | 3 |
Web of Science journal categories |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | Respiratory System | 4542 | 24% | 0% | 131 |
2 | Critical Care Medicine | 1176 | 9% | 0% | 51 |
3 | Pharmacology & Pharmacy | 785 | 24% | 0% | 130 |
4 | Medicine, General & Internal | 71 | 7% | 0% | 38 |
5 | Cardiac & Cardiovascular System | 62 | 5% | 0% | 30 |
6 | Medicine, Research & Experimental | 55 | 5% | 0% | 27 |
7 | Chemistry, Medicinal | 34 | 3% | 0% | 17 |
8 | Transplantation | 33 | 2% | 0% | 11 |
9 | Immunology | 27 | 5% | 0% | 29 |
10 | Emergency Medicine | 26 | 1% | 0% | 6 |
Address terms |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | CARDIOVASC SURG CIRCULAT PHYSIOPATHOL | 111644 | 0% | 100% | 2 |
2 | INNOVAT MED SCI | 74428 | 0% | 67% | 2 |
3 | ANESTHESIOL INTENS CARE MED CHARITE | 55822 | 0% | 100% | 1 |
4 | ASL 5 REG MARCHE | 55822 | 0% | 100% | 1 |
5 | ASL ANCONA | 55822 | 0% | 100% | 1 |
6 | BSM | 55822 | 0% | 100% | 1 |
7 | CHRISTY HOUSTON FDN | 55822 | 0% | 100% | 1 |
8 | CORP P MED AFFAIRS | 55822 | 0% | 100% | 1 |
9 | CRIT EMERGENCY CARE MED | 55822 | 0% | 100% | 1 |
10 | EDINBURGH LUNG ENVIRONM GRP INITIAT P MED UNIT | 55822 | 0% | 100% | 1 |
Journals |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | EUROPEAN JOURNAL OF RESPIRATORY DISEASES | 26467 | 5% | 2% | 26 |
2 | INVESTIGACION MEDICA INTERNACIONAL | 2505 | 0% | 2% | 2 |
3 | EUROPEAN RESPIRATORY JOURNAL | 2440 | 4% | 0% | 20 |
4 | ACTA THERAPEUTICA | 2020 | 1% | 1% | 3 |
5 | BULLETIN EUROPEEN DE PHYSIOPATHOLOGIE RESPIRATOIRE-CLINICAL RESPIRATORY PHYSIOLOGY | 1444 | 1% | 1% | 4 |
6 | CLINICAL TRIALS JOURNAL | 1409 | 1% | 1% | 3 |
7 | PULMONARY PHARMACOLOGY & THERAPEUTICS | 1351 | 1% | 0% | 6 |
8 | MULTIDISCIPLINARY RESPIRATORY MEDICINE | 1309 | 1% | 1% | 3 |
9 | DARU-JOURNAL OF PHARMACEUTICAL SCIENCES | 1182 | 1% | 1% | 3 |
10 | PRAXIS UND KLINIK DER PNEUMOLOGIE | 1107 | 0% | 1% | 2 |
Author Key Words |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | N ACETYLCYSTEINE | 686086 | 27% | 8% | 145 | Search N+ACETYLCYSTEINE | Search N+ACETYLCYSTEINE |
2 | CYTIOLONE | 111644 | 0% | 100% | 2 | Search CYTIOLONE | Search CYTIOLONE |
3 | NAC TREATMENT | 111644 | 0% | 100% | 2 | Search NAC+TREATMENT | Search NAC+TREATMENT |
4 | ACETYLCYSTEINE | 104304 | 4% | 9% | 20 | Search ACETYLCYSTEINE | Search ACETYLCYSTEINE |
5 | MUCOLYTICS | 78521 | 2% | 13% | 11 | Search MUCOLYTICS | Search MUCOLYTICS |
6 | CAS 616 91 1 | 71768 | 1% | 43% | 3 | Search CAS+616+91+1 | Search CAS+616+91+1 |
7 | N ACETYL L CYSTEINE | 71316 | 4% | 6% | 21 | Search N+ACETYL+L+CYSTEINE | Search N+ACETYL+L+CYSTEINE |
8 | EXPECTORANTS THERAPEUTIC USE | 62796 | 1% | 38% | 3 | Search EXPECTORANTS+THERAPEUTIC+USE | Search EXPECTORANTS+THERAPEUTIC+USE |
9 | 2 ALPHA THENOYLTHIO PROPIONYLGLYCINE TTPG | 55822 | 0% | 100% | 1 | Search 2+ALPHA+THENOYLTHIO+PROPIONYLGLYCINE+TTPG | Search 2+ALPHA+THENOYLTHIO+PROPIONYLGLYCINE+TTPG |
10 | 5 TRISGLUTATHION S YL HYDROQUINONE | 55822 | 0% | 100% | 1 | Search 5+TRISGLUTATHION+S+YL+HYDROQUINONE | Search 5+TRISGLUTATHION+S+YL+HYDROQUINONE |
Core articles |
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c: (1) Number of references referring to publications in the class. (2) Share of total number of active references referring to publications in the class. (3) Age of the article. New articles get higher score than old articles. (4) Citation rate, normalized to year. |
Rank | Reference | # ref. in cl. |
Shr. of ref. in cl. |
Citations |
---|---|---|---|---|
1 | POOLE, P , CHONG, J , CATES, CJ , (2015) MUCOLYTIC AGENTS VERSUS PLACEBO FOR CHRONIC BRONCHITIS OR CHRONIC OBSTRUCTIVE PULMONARY DISEASE.COCHRANE DATABASE OF SYSTEMATIC REVIEWS. VOL. . ISSUE 7. P. - | 26 | 67% | 1 |
2 | SADOWSKA, AM , MANUEL-Y-KEENOY, B , DE BACKER, WA , (2007) ANTIOXIDANT AND ANTI-INFLAMMATORY EFFICACY OF NAC IN THE TREATMENT OF COPD: DISCORDANT IN VITRO AND IN VIVO DOSE-EFFECTS: A REVIEW.PULMONARY PHARMACOLOGY & THERAPEUTICS. VOL. 20. ISSUE 1. P. 9 -22 | 36 | 47% | 118 |
3 | SAMUNI, Y , GOLDSTEIN, S , DEAN, OM , BERK, M , (2013) THE CHEMISTRY AND BIOLOGICAL ACTIVITIES OF N-ACETYLCYSTEINE.BIOCHIMICA ET BIOPHYSICA ACTA-GENERAL SUBJECTS. VOL. 1830. ISSUE 8. P. 4117 -4129 | 52 | 21% | 130 |
4 | SZAKMANY, T , HAUSER, B , RADERMACHER, P , (2012) N-ACETYLCYSTEINE FOR SEPSIS AND SYSTEMIC INFLAMMATORY RESPONSE IN ADULTS.COCHRANE DATABASE OF SYSTEMATIC REVIEWS. VOL. . ISSUE 9. P. - | 36 | 38% | 8 |
5 | POOLE, P , BLACK, PN , CATES, CJ , (2012) MUCOLYTIC AGENTS FOR CHRONIC BRONCHITIS OR CHRONIC OBSTRUCTIVE PULMONARY DISEASE.COCHRANE DATABASE OF SYSTEMATIC REVIEWS. VOL. . ISSUE 8. P. - | 22 | 61% | 5 |
6 | POOLE, P , BLACK, PN , (2010) MUCOLYTIC AGENTS FOR CHRONIC BRONCHITIS OR CHRONIC OBSTRUCTIVE PULMONARY DISEASE.COCHRANE DATABASE OF SYSTEMATIC REVIEWS. VOL. . ISSUE 2. P. - | 20 | 69% | 9 |
7 | SHEN, YF , CAI, WR , LEI, S , ZHANG, ZH , (2014) EFFECT OF HIGH/LOW DOSE N-ACETYLCYSTEINE ON CHRONIC OBSTRUCTIVE PULMONARY DISEASE: A SYSTEMATIC REVIEW AND META-ANALYSIS.COPD-JOURNAL OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE. VOL. 11. ISSUE 3. P. 351-358 | 17 | 63% | 12 |
8 | POOLE, PJ , BLACK, PN , (2006) MUCOLYTIC AGENTS FOR CHRONIC BRONCHITIS OR CHRONIC OBSTRUCTIVE PULMONARY DISEASE.COCHRANE DATABASE OF SYSTEMATIC REVIEWS. VOL. . ISSUE 3. P. - | 19 | 70% | 17 |
9 | DEKHUIJZEN, PNR , (2004) ANTIOXIDANT PROPERTIES OF N-ACETYLCYSTEINE: THEIR RELEVANCE IN RELATION TO CHRONIC OBSTRUCTIVE PULMONARY DISEASE.EUROPEAN RESPIRATORY JOURNAL. VOL. 23. ISSUE 4. P. 629-636 | 31 | 38% | 123 |
10 | TSE, HN , RAITERI, L , WONG, KY , NG, LY , YEE, KS , TSENG, CZS , (2014) BENEFITS OF HIGH-DOSE N-ACETYLCYSTEINE TO EXACERBATION-PRONE PATIENTS WITH COPD.CHEST. VOL. 146. ISSUE 3. P. 611 -623 | 18 | 53% | 9 |
Classes with closest relation at Level 1 |